Cargando…
Metformin Ameliorates Epithelial–Mesenchymal Transition of Renal Tubular Epithelial Cells in Diabetes by Increasing Vitamin D Receptor Expression
BACKGROUND: Metformin is used as a first-line drug for the treatment of type 2 diabetes. Epithelial–mesenchymal transition (EMT) plays a significant role in the development of renal tubular damage in diabetic kidney disease. However, the underlying mechanisms of EMT in diabetic kidney disease are un...
Autores principales: | Wen, Wenjie, Huang, Bin, Ye, Shandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792813/ https://www.ncbi.nlm.nih.gov/pubmed/36582506 http://dx.doi.org/10.2147/DMSO.S389918 |
Ejemplares similares
-
Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization
por: Huang, Bin, et al.
Publicado: (2022) -
AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
por: Yoshinaga, Tomoyo, et al.
Publicado: (2016) -
Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
por: SHAN, GUANG, et al.
Publicado: (2016) -
Crucial role of serum response factor in renal tubular epithelial cell epithelial-mesenchymal transition in hyperuricemic nephropathy
por: Zhao, Long, et al.
Publicado: (2019) -
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction
por: Tasanarong, Adis, et al.
Publicado: (2013)